Atlas Trials

Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer

Clinical trial NCT05299255 · UNKNOWN

Trial details

NCT number
NCT05299255
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
SCLC, Extensive Stage
Start date
2021-09-05
Primary completion
2022-09-05
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.